1,020
Participants
Start Date
July 31, 2007
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Placebo
9g /day (3 times a day)
AST-120
9g /day (3 times a day)
Phoenix
Little Rock
Alhambra
Covina
Glendale
Los Angeles
Stamford
Washington D.C.
Hudson
Miami
Ocala
Orlando
Pembroke Pines
Spring Hill
Tampa
Winter Park
Kansas City
New Orleans
Shreveport
Ypsilanti
Kansas City
St Louis
Camden
Eatontown
Port Washington
Springfield Gardens
Asheville
Cincinnati
Dayton
Toledo
Portland
Philadelphia
Pittsburgh
Rock Hill
Nashville
Arlington
Dallas
Houston
San Antonio
Appleton
Oshkosh
Buenos Aires
Córdoba
San Luis
San Miguel de Tucumán
San Pedro
Barao Geraldo-Campinas
Belo Horizonte Minas Gerais
Juiz de Fora
Porto Alegre
Rio de Janeiro
São Paulo
Taubaté
Winnipeg
Brampton
Kitzhener
Oakville
Scarborough Village
Toronto
Montreal
České Budějovice
Jihlava
Ostrava - Poruba
Prague
Tábor
Grenoble
Lyon
Nantes
Saint-Lô
Bologna
Brescia
Como
Pavia
Aguascalientes
Mexico City
Tijuana
Gdansk
Szczecin
Torun
Warsaw
Caguas
Bamaul
Kazan'
Krasnodar
Moscow
Nizhny Novgorod
Novosibirsk
Pyatigorsk
Ryazan
Saint Petersburg
Saratov
Smolensk
Sochi
Stavropol
Yekaterinburg
Chernivtsi
Dnipropetrovsk
Donetsk
Ivano-Frankivsk
Kharkiv
Kiev
Odesa
Uzhhorod
Vinnitsa
Zhytomyr
Lead Sponsor
Collaborators (1)
Kureha Corporation
INDUSTRY
Mitsubishi Tanabe Pharma Corporation
INDUSTRY